# Use of Incretins in Diabetic Patients

> **NCT03486964** · — · COMPLETED · sponsor: **University of Pavia** · enrollment: 2234 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** DPP-4 inhibitors

## Key facts

- **NCT ID:** NCT03486964
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-27
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-05-30
- **Target enrollment:** 2234 (ACTUAL)
- **Last updated:** 2022-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03486964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03486964, "Use of Incretins in Diabetic Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03486964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*